![]() |
市場調查報告書
商品編碼
2026784
預填充式注射器市場預測至2034年-按類型、材質、設計、通路、應用和地區分類的全球分析Prefilled Syringes Market Forecasts to 2034 - Global Analysis By Type, By Material, Design, Distribution Channel, Application and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球預填充式注射器市場規模將達到 117 億美元,並在預測期內以 12.9% 的複合年成長率成長,到 2034 年將達到 308 億美元。
預填充式注射器是醫療設備,可直接使用。它由注射器主體、活塞和針頭組成,為藥物給藥提供便利、精準和安全保障。預填充式注射器可減少給藥錯誤,最大限度地降低污染風險,簡化醫療流程,滿足從疫苗和生物製藥到慢性病管理和急診醫學等各種治療中的多樣化醫療需求。
根據日內瓦協會發布的報告,在過去 20 年裡,全球整體醫療保健總支出佔 GDP 的比例從約 8% 增加到近 10%,估計每年達到 8 兆美元。
慢性病盛行率上升
糖尿病、自體免疫疾病和各種神經系統疾病等慢性病發病率的上升正在推動預填充式注射器市場的成長。這些疾病需要定期、準確地給藥,因此對預填充式注射器預填充式注射器具有方便、用藥精準、降低污染和用藥錯誤風險等優點,能夠滿足需要頻繁用藥的患者的需求。此外,隨著醫療專業人員擴大選擇高效、即用型的解決方案來改善患者照護和疾病管理,這些慢性病的日益普遍也進一步鞏固了市場的成長勢頭。
注射量的限制
雖然這些注射器為許多藥物提供了便利和精確的劑量控制,但它們的注射容量通常是固定的或有限的。這種限制會影響需要較高劑量或劑量可變的藥物。對於超過注射器容量的藥物,必須考慮其他給藥系統,這限制了預充式預填充式注射器在所有藥物類型中的普遍應用。這種無法滿足不同劑量需求的限制阻礙了預填充式注射器在特定治療領域的廣泛應用,並影響了其市場滲透率。
新興市場醫療基礎設施的擴張
新興市場醫療基礎設施的擴張為預填充式注射器市場帶來了巨大的機會。這些地區醫療機構數量大幅成長,導致對高效且經濟的給藥系統需求日益成長。此外,在資源有限的環境中,預充式注射器在給藥和儲存方面的高效性也增強了其吸引力,從而推動了預填充式注射器在新興經濟體快速發展的醫療基礎設施中的應用和市場擴張。
嚴格的監管要求和核准流程
嚴格的監管要求和核准流程對預填充式注射器市場構成重大威脅。企業必須遵守複雜的監管標準,尤其是在材料適用性、生產標準和無菌性方面,這延長了產品開發和市場准入所需的時間和資源。合規性方面的挑戰可能導致核准延遲、開發成本增加,並扼殺創新。這些嚴格的法規為新進入者設置了障礙,影響市場競爭力並阻礙市場成長。
新冠疫情對預填充式注射器市場產生了重大影響。全球疫苗宣傳活動對疫苗的迫切需求,導致對預填充式注射器的需求激增,以有效率地進行疫苗接種。製造商為滿足全球疫苗供應需求,不得不提高產量,這造成了供應鏈挑戰,並加劇了原料競爭。此外,嚴格的安全措施、監管合規要求以及對大規模疫苗宣傳活動的重視,加速了預填充式注射器技術的創新和投資,以確保安全、高效且擴充性的疫苗接種解決方案。
在預測期內,玻璃細分市場預計將佔據最大的市場佔有率。
預計玻璃材質的預填充式注射器將佔據市場最大佔有率。玻璃具有優異的性能,例如化學惰性,確保了其穩定性以及與多種藥物的相容性。其透明性便於目視檢查,這對藥物的完整性至關重要。隨著生物製藥和精細製劑需求的不斷成長,玻璃的阻隔性備受青睞。此外,人們對藥物交互作用的日益關注以及對精準給藥的需求,進一步強化了對玻璃材質的偏好,鞏固了其在預填充式注射器市場的主導地位。
在預測期內,預計網路商店細分市場將呈現最高的複合年成長率。
受醫療保健產業電子商務蓬勃發展的推動,預計預填充式注射器市場中,網路商店板塊將呈現最高的成長率。線上平台為消費者提供便利、便利的購物體驗和豐富的商品選擇。隨著數位化平台的日益普及,患者和醫療專業人員更傾向於在線訂購醫療用品,因為這種方式更加便利。全球持續推進的數位轉型以及對非接觸式交易的重視,進一步推動了預填充式注射器市場網路商店的快速成長。
由於北美擁有完善的醫療保健基礎設施、對先進醫療技術的高度認知以及對注射藥物的強勁需求,預計北美將佔據預填充式注射器市場最大的佔有率。該地區成熟的製藥產業,加上對研發的大量投入,鞏固了北美作為預預填充式注射器主要市場的地位。此外,以患者為中心的給藥方式的日益普及也進一步推動了預填充式注射器的應用,從而鞏固了北美的市場主導地位。
亞太地區預填充式注射器市場的強勁成長主要得益於醫療基礎設施的持續改善、醫藥產業投資的增加以及對病人安全日益重視。不斷成長的醫療支出、龐大的患者群體以及政府推廣先進醫療技術的舉措,都推動了對預填充式注射器的需求。此外,該地區疫苗接種計劃的擴展以及慢性病盛行率的上升,也促進了預填充式注射器的應用。
According to Stratistics MRC, the Global Prefilled Syringes Market is accounted for $11.7 billion in 2026 and is expected to reach $30.8 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Prefilled syringes are ready-to-use medical devices containing a premeasured dose of medication, sealed and sterilized for single-use injection. Comprising a barrel, plunger and needle, they offer convenience, accuracy, and safety in drug administration. Prefilled syringes reduce dosing errors, contamination risks and streamline medical procedures, catering to diverse healthcare needs across various treatments, from vaccines and biologics to chronic disease management and emergency medicine.
According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum.
Rising prevalence of chronic diseases
The escalating incidence of chronic illnesses, such as diabetes, autoimmune disorders, and various neurological conditions, has propelled the prefilled syringes market. These conditions require regular and precise medication dosages, fostering the demand for user-friendly, accurate drug delivery systems like prefilled syringes. Offering convenience, dosage accuracy and reduced risks of contamination or dosage errors, prefilled syringes address the needs of patients requiring frequent medication. Additionally, this rising prevalence of chronic diseases emphasizes the market's growth trajectory as healthcare providers increasingly opt for efficient, ready-to-administer solutions to enhance patient care and management of these conditions.
Injection volume limitations
These syringes offer convenience and accurate dosing for many medications, they often come with fixed or limited injection volumes. This constraint affects certain drugs requiring larger doses or those with variable dosage needs. For medications that exceed the syringe's volume capacity, alternative delivery systems must be considered, limiting the universal applicability of prefilled syringes across all medication types. This limitation in accommodating diverse dosage requirements restrains their widespread adoption in certain therapeutic areas, impacting their market penetration.
Growing healthcare infrastructure across emerging markets
The expanding healthcare infrastructure in emerging markets presents a significant opportunity for the prefilled syringes market. As these regions witness substantial growth in medical facilities, there's a heightened demand for efficient and cost-effective drug delivery systems. Additionally, their potential for streamlined administration and storage in resource-limited settings enhances their attractiveness, driving their adoption and market expansion within burgeoning healthcare infrastructures across emerging economies.
Stringent regulatory requirements and approval processes
Stringent regulatory requirements and approval processes pose a significant threat to the prefilled syringes market. The need to adhere to complex regulatory standards, especially regarding material compatibility, manufacturing standards and sterility assurance, prolongs the time and resources required for product development and market entry. Compliance challenges may lead to delays in approvals, increasing development costs and potentially limiting innovation. These rigorous regulations create barriers for new entrants, impacting market competitiveness and hindering market growth.
The COVID-19 pandemic significantly impacted the prefilled syringes market. The urgent need for vaccination campaigns worldwide propelled demand for prefilled syringes to administer vaccines efficiently. Manufacturers faced increased production to meet global vaccine distribution requirements, leading to supply chain challenges and heightened competition for materials. Additionally, stringent safety measures, regulatory adaptations and the focus on mass vaccination campaigns accelerated innovation and investment in prefilled syringe technologies to ensure safe, efficient and scalable vaccine delivery solutions.
The glass segment is expected to be the largest during the forecast period
The glass segment is anticipated to secure the largest market share in prefilled syringes. Glass offers superior qualities such as chemical inertness, ensuring stability and compatibility with a wide range of medications. Its transparency enables easy visual inspection, which is crucial for drug integrity. With an increasing demand for biologics and sensitive formulations, glass's barrier properties against moisture and gases are preferred. Moreover, heightened concerns about drug interaction and the need for precise drug delivery amplify the preference for glass, solidifying its dominance in the prefilled syringes market.
The online stores segment is expected to have the highest CAGR during the forecast period
The online store segment is expected to witness the highest growth rate in the prefilled syringes market due to the increasing trend of e-commerce in healthcare. Online platforms provide convenience, accessibility, and a wide product range for consumers. With the rising adoption of digital platforms, patients and healthcare providers prefer the ease of ordering medical supplies online. The ongoing global shift towards digitalization and emphasizing contactless transactions further drives the anticipated rapid growth of online stores in the prefilled syringes market.
North America is poised to secure the largest market share in prefilled syringes due to a robust healthcare infrastructure, high awareness of advanced medical technologies, and a surge in demand for injectable drugs. The region's well-established pharmaceutical industry, coupled with significant investments in research and development, positions it as a key market for prefilled syringes. Additionally, increased focus on patient-centric drug delivery further fuels the adoption of prefilled syringes, contributing to North America's dominant position in the market.
Asia Pacific's robust growth in the prefilled syringes market is attributed to the region's expanding healthcare infrastructure, rising investments in pharmaceuticals and a growing emphasis on patient safety. Increasing healthcare expenditure, a large patient population and government initiatives promoting advanced healthcare technologies drive the demand for prefilled syringes. Moreover, the region's escalating vaccination programs, coupled with the burgeoning prevalence of chronic diseases, bolster the adoption of prefilled syringes.
Key players in the market
Some of the key players in prefilled syringes market include BD (Becton, Dickinson and Company), Catalent, Daikyo Seiko, Ltd., Gerresheimer, Haselmeier GmbH, Nemera, Nipro Corporation, Recipharm, SCHOTT AG, SHL Group, Stevanato Group, Terumo Corporation, Vaccinex, Inc., Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., Wuxi AppTec and Ypsomed.
In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60(R) Infusion System with Hizentra(R) 50 mL Prefilled Syringes.
In May 2023, Nexus Pharmaceuticals announced the FDA approval of single-dose prefilled syringes for Emerphed(R) (ephedrine sulfate injection) used for the treatment of clinically important hypotension occurring in the setting of anesthesia.
In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.